查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1601595

导管及积极嵌入式设备的CDMO的全球市场:服务范畴·终端用户·不同地区的预测 (～2032年)

Global Catheters and Active Implantable CDMO Market Research Report Information by Service Category, By End-Users And By Region -Market Forecast Till 2032
出版日期: | 出版商: Market Research Future | 英文 187 Pages | 订单完成后即时交付

价格

导管与主动植入器材 CDMO 市场规模预计将从 2023 年的 69.2 亿美元成长到 2024 年的 74.9 亿美元，预测期内复合年增长率为 10.82%，到 2032 年预计将成长到188亿美元。

市场扩张是由与导管和主动植入设备 CDMO 相关的策略性举措的增加以及製造外包的增加所推动的。

不断涌现的举措正在推动技术创新、改善市场准入并显着提振市场。策略併购使组织能够提供全面的解决方案，汇集资源和知识来加速产品开发。同时，医疗基础设施投资的增加，尤其是在新兴国家，以及对微创手术的日益偏好，正在增加先进导管和植入式设备的使用。

区域洞察

北美地区在 2023 年占据最大的市场占有率，预计在预测期内将会成长。同时，预计亚太地区在预测期内将以最快的复合年增长率成长。

由于技术发展、有利的监管环境和不断增长的医疗保健需求，北美市场正在迅速扩张。此外，该市场是由先进的医疗基础设施和研发方面的大量投资推动的，这使得尖端植入设备的开发成为可能。此外，向新兴国家的潜在扩张、个人化治疗的兴起以及对微创解决方案的需求都指向了成长路径。

由于技术进步和不断增长的医疗保健需求，欧洲市场具有巨大的成长潜力。下一代心臟起搏器、神经刺激器和胰岛素帮浦等植入式设备技术的进步正在推动对专业製造能力的需求。由于人口老化，慢性病的发生率不断增加，这也增加了对复杂、高品质植入式治疗的需求。

亚太市场出现了显着成长，预计将成为预测期内成长最快的地区。几个关键推动因素正在推动强劲成长。中国、印度和日本等国家医疗技术的快速进步和医疗基础设施投资的增加正在推动对先进植入设备的需求。慢性病、糖尿病盛行率的增加以及人口老化正在增加对新疗法的需求。

本报告提供全球导管及积极嵌入式设备的CDMO的市场调查，彙整市场定义和概要，市场成长的各种影响因素分析，市场规模的转变·预测，各种区分·地区/各主要国家的明细，竞争环境，主要企业简介等资讯。

目录

第1章 摘要整理

第2章 市场概要

第3章 调查手法

第4章 市场动态

  • 促进因素
    • 增加与导管和主动植入设备 CDMO 相关的策略性举措
    • 製造外包增加
  • 阻碍因素
    • 严格的法规和政策
  • 机会
    • 全球老化
    • 透过 CDMO 扩大设施

第5章 市场要素分析

  • 波特的五力分析
  • COVID-19对市场带来的影响
  • 市场趋势

第6章 导管及积极嵌入式设备的CDMO市场:不同服务类别的

  • 概要
  • 导管
    • 心导管
    • 泌尿科导管
    • 神经血管导管
    • 其他
  • 积极嵌入式设备
    • 神经调节设备
    • 结构的心臟设备
    • 心臟衰竭设备
    • 泌尿科用嵌入式设备
    • 其他
  • 内视镜设备
  • 其他

第7章 导管及积极嵌入式设备的CDMO市场:各终端用户

  • 概要
  • 医疗设备OEM企业
  • 学术研究机关
  • 政府机关

第8章 导管及积极嵌入式设备的CDMO市场:各地区

  • 概要
  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 其他
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 其他
  • 其他地区
    • 中东·非洲
    • 南美

第9章 竞争情形

  • 市场占有率分析
  • 竞争仪表板
  • 上市公司的股票概要
  • 比较分析:主要企业的财务趋势
  • 主要的展开与成长策略

第10章 企业简介

  • INTEGER HOLDINGS CORPORATION
  • CIRTEC
  • BIOMERICS
  • SWITCHBACK MEDICAL
  • VELENTIUM LLC
  • HERAEUS GROUP
  • ZEUS COMPANY LLC
  • VERANEX
  • FREUDENBERG MEDICAL
  • MEDEOLOGIX
  • DATA CITATIONS
Product Code: MRFR/HC/25126-CR

Global Catheters and Active Implantable CDMO Market Research Report Information by Service Category (Catheters, Active Implantable Devices, Endoscopy Devices, and Others), By End-Users (Medical Device OEM Companies, Academic and Research Institutes, and Government Agencies) And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) -Market Forecast Till 2032

Market Overview

The Catheters and Active Implantable CDMO Market was valued at USD 6.92 billion in 2023. The market is expected to increase from USD 7.49 billion in 2024 to USD 18.8 billion by 2032, with a compound annual growth rate (CAGR) of 10.82% for the forecast period (2024-2032).

The market expansion is being driven by increased strategic initiatives connected with catheters and active implantable CDMO, as well as increased production outsourcing.

Growing initiatives are promoting innovation and enhancing market accessibility, significantly boosting the global market for catheters and active implanted CDMOs. Strategic mergers and acquisitions enable organizations to offer comprehensive solutions and accelerate product development by pooling resources and knowledge. Simultaneously, the use of advanced catheters and implantable devices is increasing as a result of increased investments in healthcare infrastructure, particularly in emerging nations, and a growing preference for less intrusive procedures.

Market Segment insights

The Catheters and Active Implantable CDMO Market is divided into three service segments: catheters, active implantable devices, and endoscopy devices.

The Catheters and Active Implantable CDMO Market is divided into three end user segments: medical device OEM firms, academic and research organizations, and government agencies.

Regional insights

North America held the biggest market share in 2023 and is expected to grow over the forecast period. However, Asia-Pacific is expected to develop at the fastest CAGR over the forecast period.

The Active Implantable CDMO market in North America is expanding rapidly, owing to technical developments, a favorable regulatory environment, and rising healthcare demands. Furthermore, the market is driven by sophisticated healthcare infrastructure and significant investment in R&D, which allows for the development of cutting-edge implantable devices. Furthermore, potential for development into emerging countries, the rise of customized treatment, and the demand for minimally invasive solutions offer paths for growth.

The Americas region is followed by Europe, which is further divided into Germany, France, the United Kingdom, Italy, Spain, and the Rest of Europe. The Active Implantable CDMO market in Europe has great growth potential, driven by technological advancements and rising healthcare demands. Implantable device technology improvements, such as next-generation cardiac pacemakers, neurostimulators, and insulin pumps, are driving up demand for specialized manufacturing capabilities. The rising frequency of chronic diseases, fueled by an aging population, heightens the demand for complex, high-quality implantable treatments.

Asia-Pacific is predicted to show significant growth and is projected to be the fastest growing region throughout the projection period. Several important drivers are driving robust growth. Rapid improvements in medical technology, as well as increased investment in healthcare infrastructure in nations such as China, India, and Japan, are driving demand for advanced implantable devices. The increased prevalence of chronic diseases, diabetes, and an aging population increase the demand for novel remedies.

Major Players

Major competitors in the Catheters and Active Implantable CDMO Market include Integer Holdings Corporation (US), Cirtec (US), Biomerics (US), Switchback Medical (US), Velentium LLC (US), Heraeus Group (Germany), Zeus Company LLC (US), Veranex (US), Freudenberg Medical (US), and Medeologix (Taiwan).

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

  • 2.1 DEFINITION
  • 2.2 SCOPE OF THE STUDY
  • 2.3 RESEARCH OBJECTIVE
  • 2.4 MARKET STRUCTURE

3 RESEARCH METHODOLOGY

  • 3.1 OVERVIEW
  • 3.2 DATA FLOW
    • 3.2.1 Data Mining Process
  • 3.3 PURCHASED DATABASE:
  • 3.4 SECONDARY SOURCES:
    • 3.4.1 Secondary Research data flow:
  • 3.5 PRIMARY RESEARCH:
    • 3.5.1 Primary Research DATA FLOW:
    • 3.5.2 Primary Research: Number of Interviews conducted
    • 3.5.3 Primary Research: Regional Coverage
  • 3.6 APPROACHES FOR MARKET SIZE ESTIMATION:
    • 3.6.1 Revenue Analysis Approach
  • 3.7 DATA FORECASTING
    • 3.7.1 Data forecasting Technique
  • 3.8 DATA MODELING
    • 3.8.1 microeconomic factor analysis:
    • 3.8.2 Data modeling:
  • 3.9 TEAMS AND ANALYST CONTRIBUTION

4 MARKET DYNAMICS

  • 4.1 INTRODUCTION
  • 4.2 DRIVERS
    • 4.2.1 Increasing strategic initiatives associated with Catheters and Active Implantable CDMO
    • 4.2.2 Increased Outsourcing of Manufacturing
  • 4.3 RESTRAINTS
    • 4.3.1 Stringent regulatory Policies
  • 4.4 OPPORTUNITY
    • 4.4.1 Growing geriatric population across the globe
    • 4.4.2 FACILITY EXPANSION by Contract Development Manuacturing Organization

5 MARKET FACTOR ANALYSIS

  • 5.1 PORTER'S FIVE FORCES MODEL
    • 5.1.1 Threat of New Entrants
    • 5.1.2 Bargaining Power of Suppliers
    • 5.1.3 Threat of Substitutes
    • 5.1.4 Bargaining Power of Buyers
    • 5.1.5 Intensity of Rivalry
  • 5.2 IMPACT OF COVID-19 ON THE GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET
  • 5.3 TRENDS IN CDMO FOR CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET
    • 5.3.1 Shifting Focus of Medical Device CDMOs to Improve Capabilities

6 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY SERVICE CATEGORY

  • 6.1 OVERVIEW
  • 6.2 CATHETERS
    • 6.2.1 Cardiac Catheters
    • 6.2.2 Urology Catheters
    • 6.2.3 Neurovascular Catheters
    • 6.2.4 Others
  • 6.3 ACTIVE IMPLANTABLE DEVICES
    • 6.3.1 Neuromodulation Devices
      • 6.3.1.1 Spinal Cord Stimulators
      • 6.3.1.2 Deep Brain Stimulators
      • 6.3.1.3 Others
    • 6.3.2 Structural Heart Devices
      • 6.3.2.1 Valve Implants
      • 6.3.2.2 Stents & Shunts
      • 6.3.2.3 Others
    • 6.3.3 Heart Failure Devices
      • 6.3.3.1 Percutaneous Left Ventricular Assist Device (LVAD)
      • 6.3.3.2 Percutaneous Right Ventricular Support Devices (RVAD)
      • 6.3.3.3 Others
    • 6.3.4 Urology Implantable Devices
    • 6.3.5 Others
  • 6.4 ENDOSCOPY DEVICES
  • 6.5 OTHERS

7 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY END USER

  • 7.1 OVERVIEW
  • 7.2 MEDICAL DEVICE OEM COMPANIES
  • 7.3 ACADEMIC AND RESEARCH INSTITUTES
  • 7.4 GOVERNMENT AGENCIES

8 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY REGION

  • 8.1 OVERVIEW
  • 8.2 NORTH AMERICA
    • 8.2.1 US
    • 8.2.2 Canada
  • 8.3 EUROPE
    • 8.3.1 Germany
    • 8.3.2 France
    • 8.3.3 UK
    • 8.3.4 Italy
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 ASIA-PACIFIC
    • 8.4.1 China
    • 8.4.2 India
    • 8.4.3 Japan
    • 8.4.4 South Korea
    • 8.4.5 Australia
    • 8.4.6 Rest of Asia-Pacific
  • 8.5 REST OF THE WORLD
    • 8.5.1 Middle East & Africa
    • 8.5.2 South America

9 COMPETITIVE LANDSCAPE

  • 9.1 INTRODUCTION
  • 9.2 MARKET SHARE ANALYSIS,
  • 9.3 COMPETITOR DASHBOARD
  • 9.4 PUBLIC PLAYERS STOCK SUMMARY
  • 9.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL
  • 9.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
    • 9.6.1 Facility expansion
    • 9.6.2 Acquisition
    • 9.6.3 Partnership

10 COMPANY PROFILES

  • 10.1 INTEGER HOLDINGS CORPORATION
    • 10.1.1 COMPANY OVERVIEW
    • 10.1.2 FINANCIAL OVERVIEW
    • 10.1.3 productS OFFERED
    • 10.1.4 KEY DEVELOPMENTS
    • 10.1.5 SWOT ANALYSIS
    • 10.1.6 KEY STRATEGIES
  • 10.2 CIRTEC
    • 10.2.1 COMPANY OVERVIEW
    • 10.2.2 FINANCIAL OVERVIEW
    • 10.2.3 PRODUCT OFFERED
    • 10.2.4 KEY DEVELOPMENTS
    • 10.2.5 SWOT ANALYSIS
    • 10.2.6 KEY STRATEGIES
  • 10.3 BIOMERICS
    • 10.3.1 COMPANY OVERVIEW
    • 10.3.2 FINANCIAL OVERVIEW
    • 10.3.3 PRODUCTS OFFERED
    • 10.3.4 KEY DEVELOPMENTS
    • 10.3.5 KEY STRATEGIES
  • 10.4 SWITCHBACK MEDICAL
    • 10.4.1 COMPANY OVERVIEW
    • 10.4.2 FINANCIAL OVERVIEW
    • 10.4.3 PRODUCTS OFFERED
    • 10.4.4 KEY DEVELOPMENTS
    • 10.4.5 SWOT ANALYSIS
    • 10.4.6 KEY STRATEGIES
  • 10.5 VELENTIUM LLC
    • 10.5.1 COMPANY OVERVIEW
    • 10.5.2 FINANCIAL OVERVIEW
    • 10.5.3 PRODUCTS OFFERED
    • 10.5.4 KEY DEVELOPMENTS
    • 10.5.5 KEY STRATEGIES
  • 10.6 HERAEUS GROUP
    • 10.6.1 COMPANY OVERVIEW
    • 10.6.2 FINANCIAL OVERVIEW
    • 10.6.3 PRODUCTS OFFERED
    • 10.6.4 KEY DEVELOPMENTS
    • 10.6.5 SWOT ANALYSIS
    • 10.6.6 KEY STRATEGIES
  • 10.7 ZEUS COMPANY LLC
    • 10.7.1 COMPANY OVERVIEW
    • 10.7.2 FINANCIAL OVERVIEW
    • 10.7.3 PRODUCTS OFFERED
    • 10.7.4 KEY DEVELOPMENTS
    • 10.7.5 SWOT ANALYSIS
    • 10.7.6 KEY STRATEGIES
  • 10.8 VERANEX
    • 10.8.1 COMPANY OVERVIEw
    • 10.8.2 FINANCIAL OVERVIEW
    • 10.8.3 Product OFFERed
    • 10.8.4 KEY DEVELOPMENTS
    • 10.8.5 KEY STRATEGIES
  • 10.9 FREUDENBERG MEDICAL
    • 10.9.1 COMPANY OVERVIEW
    • 10.9.2 FINANCIAL OVERVIEW
    • 10.9.3 PRODUCTS OFFERED
    • 10.9.4 KEY DEVELOPMENTS
    • 10.9.5 KEY STRATEGIES
  • 10.10 MEDEOLOGIX
    • 10.10.1 COMPANY OVERVIEW
    • 10.10.2 FINANCIAL OVERVIEW
    • 10.10.3 PRODUCTS OFFERED
    • 10.10.4 KEY DEVELOPMENTS
    • 10.10.5 KEY STRATEGIES
  • 10.11 DATA CITATIONS

LIST OF TABLES

  • TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT
  • TABLE 1 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY SERVICE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 2 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR CATHETERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 3 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR CATHETERS, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 4 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR CARDIAC CATHETERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 5 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR UROLOGY CATHETERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 6 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR NEUROVASCULAR CATHETERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR OTHERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR ACTIVE IMPLANTABLE DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 9 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR ACTIVE IMPLANTABLE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 10 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR NEUROMODULATION DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR NEUROMODULATION DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 12 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR SPINAL CORD STIMULATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR DEEP BRAIN STIMULATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR OTHERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 15 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR STRUCTURAL HEART DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR STRUCTURAL HEART DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 17 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR VALVE IMPLANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR STENTS & SHUNTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR OTHERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR HEART FAILURE DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR HEART FAILURE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 22 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR PERCUTANEOUS LEFT VENTRICULAR ASSIST DEVICE (LVAD), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR PERCUTANEOUS RIGHT VENTRICULAR SUPPORT DEVICES (RVAD), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR OTHERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR UROLOGY IMPLANTABLE DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR OTHERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR ENDOSCOPY DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR OTHERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 30 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR MEDICAL DEVICE OEM COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR GOVERNMENT AGENCIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 34 NORTH AMERICA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35 NORTH AMERICA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY SERVICE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 36 NORTH AMERICA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR CATHETERS, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 37 NORTH AMERICA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR ACTIVE IMPLANTABLE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 38 NORTH AMERICA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR NEUROMODULATION DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 39 NORTH AMERICA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR STRUCTURAL HEART DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 40 NORTH AMERICA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR HEART FAILURE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 41 NORTH AMERICA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 42 US: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY SERVICE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 43 US: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR CATHETERS, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 44 US: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR ACTIVE IMPLANTABLE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 45 US: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR NEUROMODULATION DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 46 US: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR STRUCTURAL HEART DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 47 US: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR HEART FAILURE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 48 US: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 49 CANADA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY SERVICE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 50 CANADA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR CATHETERS, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 51 CANADA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR ACTIVE IMPLANTABLE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 52 CANADA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR NEUROMODULATION DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 53 CANADA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR STRUCTURAL HEART DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 54 CANADA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR HEART FAILURE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 55 CANADA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 56 EUROPE: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57 EUROPE: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY SERVICE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 58 EUROPE: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR CATHETERS, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 59 EUROPE: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR ACTIVE IMPLANTABLE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 60 EUROPE: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR NEUROMODULATION DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 61 EUROPE: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR STRUCTURAL HEART DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 62 EUROPE: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR HEART FAILURE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 63 EUROPE: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 64 GERMANY: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY SERVICE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 65 GERMANY: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR CATHETERS, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 66 GERMANY: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR ACTIVE IMPLANTABLE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 67 GERMANY: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR NEUROMODULATION DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 68 GERMANY: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR STRUCTURAL HEART DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 69 GERMANY: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR HEART FAILURE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 70 GERMANY: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 71 FRANCE: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY SERVICE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 72 FRANCE: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR CATHETERS, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 73 FRANCE: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR ACTIVE IMPLANTABLE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 74 FRANCE: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR NEUROMODULATION DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 75 FRANCE: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR STRUCTURAL HEART DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 76 FRANCE: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR HEART FAILURE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 77 FRANCE: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 78 UK: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY SERVICE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 79 UK: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR CATHETERS, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 80 UK: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR ACTIVE IMPLANTABLE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 81 UK: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR NEUROMODULATION DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 82 UK: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR STRUCTURAL HEART DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 83 UK: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR HEART FAILURE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 84 UK: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 85 ITALY: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY SERVICE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 86 ITALY: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR CATHETERS, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 87 ITALY: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR ACTIVE IMPLANTABLE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 88 ITALY: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR NEUROMODULATION DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 89 ITALY: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR STRUCTURAL HEART DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 90 ITALY: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR HEART FAILURE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 91 ITALY: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 92 SPAIN: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY SERVICE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 93 SPAIN: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR CATHETERS, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 94 SPAIN: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR ACTIVE IMPLANTABLE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 95 SPAIN: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR NEUROMODULATION DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 96 SPAIN: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR STRUCTURAL HEART DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 97 SPAIN: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR HEART FAILURE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 98 SPAIN: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 99 REST OF EUROPE: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY SERVICE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 100 REST OF EUROPE: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR CATHETERS, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 101 REST OF EUROPE: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR ACTIVE IMPLANTABLE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 102 REST OF EUROPE: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR NEUROMODULATION DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 103 REST OF EUROPE: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR STRUCTURAL HEART DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 104 REST OF EUROPE: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR HEART FAILURE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 105 REST OF EUROPE: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 106 ASIA-PACIFIC: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107 ASIA-PACIFIC: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY SERVICE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 108 ASIA-PACIFIC: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR CATHETERS, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 109 ASIA-PACIFIC: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR ACTIVE IMPLANTABLE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 110 ASIA-PACIFIC: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR NEUROMODULATION DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 111 ASIA-PACIFIC: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR STRUCTURAL HEART DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 112 ASIA-PACIFIC: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR HEART FAILURE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 113 ASIA-PACIFIC: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 114 CHINA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY SERVICE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 115 CHINA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR CATHETERS, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 116 CHINA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR ACTIVE IMPLANTABLE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 117 CHINA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR NEUROMODULATION DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 118 CHINA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR STRUCTURAL HEART DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 119 CHINA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR HEART FAILURE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 120 CHINA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 121 INDIA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY SERVICE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 122 INDIA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR CATHETERS, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 123 INDIA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR ACTIVE IMPLANTABLE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 124 INDIA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR NEUROMODULATION DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 125 INDIA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR STRUCTURAL HEART DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 126 INDIA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR HEART FAILURE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 127 INDIA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 128 JAPAN: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY SERVICE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 129 JAPAN: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR CATHETERS, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 130 JAPAN: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR ACTIVE IMPLANTABLE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 131 JAPAN: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR NEUROMODULATION DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 132 JAPAN: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR STRUCTURAL HEART DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 133 JAPAN: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR HEART FAILURE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 134 JAPAN: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 135 SOUTH KOREA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY SERVICE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 136 SOUTH KOREA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR CATHETERS, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 137 SOUTH KOREA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR ACTIVE IMPLANTABLE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 138 SOUTH KOREA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR NEUROMODULATION DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 139 SOUTH KOREA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR STRUCTURAL HEART DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 140 SOUTH KOREA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR HEART FAILURE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 141 SOUTH KOREA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 142 AUSTRALIA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY SERVICE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 143 AUSTRALIA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR CATHETERS, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 144 AUSTRALIA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR ACTIVE IMPLANTABLE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 145 AUSTRALIA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR NEUROMODULATION DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 146 AUSTRALIA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR STRUCTURAL HEART DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 147 AUSTRALIA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR HEART FAILURE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 148 AUSTRALIA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 149 REST OF ASIA-PACIFIC: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY SERVICE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 150 REST OF ASIA-PACIFIC: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR CATHETERS, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 151 REST OF ASIA-PACIFIC: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR ACTIVE IMPLANTABLE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 152 REST OF ASIA-PACIFIC: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR NEUROMODULATION DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 153 REST OF ASIA-PACIFIC: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR STRUCTURAL HEART DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 154 REST OF ASIA-PACIFIC: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR HEART FAILURE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 155 REST OF ASIA-PACIFIC: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 156 REST OF THE WORLD: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157 REST OF THE WORLD: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY SERVICE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 158 REST OF THE WORLD: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR CATHETERS, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 159 REST OF THE WORLD: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR ACTIVE IMPLANTABLE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 160 REST OF THE WORLD: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR NEUROMODULATION DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 161 REST OF THE WORLD: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR STRUCTURAL HEART DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 162 REST OF THE WORLD: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR HEART FAILURE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 163 REST OF THE WORLD: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 164 MIDDLE EAST & AFRICA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY SERVICE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 165 MIDDLE EAST & AFRICA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR CATHETERS, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 166 MIDDLE EAST & AFRICA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR ACTIVE IMPLANTABLE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 167 MIDDLE EAST & AFRICA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR NEUROMODULATION DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 168 MIDDLE EAST & AFRICA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR STRUCTURAL HEART DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 169 MIDDLE EAST & AFRICA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR HEART FAILURE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 170 MIDDLE EAST & AFRICA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 171 SOUTH AMERICA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY SERVICE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 172 SOUTH AMERICA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR CATHETERS, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 173 SOUTH AMERICA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR ACTIVE IMPLANTABLE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 174 SOUTH AMERICA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR NEUROMODULATION DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 175 SOUTH AMERICA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR STRUCTURAL HEART DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 176 SOUTH AMERICA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, FOR HEART FAILURE DEVICES, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 177 SOUTH AMERICA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 178 FACILITY EXPANSION
  • TABLE 179 ACQUISITION
  • TABLE 180 PARTNERSHIP
  • TABLE 181 INTEGER HOLDINGS CORPORATION: PRODUCT OFFERED
  • TABLE 182 INTEGER HOLDINGS CORPORATION: KEY DEVELOPMENTS
  • TABLE 183 CIRTEC: PRODUCTS OFFERED
  • TABLE 184 CIRTEC: KEY DEVELOPMENTS
  • TABLE 185 BIOMERICS: PRODUCTS OFFERED
  • TABLE 186 BIOMERICS: KEY DEVELOPMENTS
  • TABLE 187 SWITCHBACK MEDICAL: PRODUCTS OFFERED
  • TABLE 188 VELENTIUM LLC: PRODUCTS OFFERED
  • TABLE 189 HERAEUS GROUP: PRODUCTS OFFERED
  • TABLE 190 ZEUS COMPANY LLC: PRODUCTS OFFERED
  • TABLE 191 VERANEX: PRODUCTS OFFERED
  • TABLE 192 FREUDENBERG MEDICAL: PRODUCTS OFFERED
  • TABLE 193 MEDEOLOGIX: PRODUCTS OFFERED

LIST OF FIGURES

  • FIGURE 1 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET: STRUCTURE
  • FIGURE 2 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET: MARKET GROWTH FACTOR ANALYSIS (2023-2032)
  • FIGURE 3 DRIVER IMPACT ANALYSIS (2023-2032)
  • FIGURE 4 RESTRAINT IMPACT ANALYSIS (2023-2032)
  • FIGURE 5 PORTER'S FIVE FORCES ANALYSIS: GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET
  • FIGURE 6 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, SERVICE CATEGORY, 2023 & 2032 (USD MILLION)
  • FIGURE 7 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY SERVICE CATEGORY, 2023 & 2032 (USD MILLION)
  • FIGURE 8 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET SHARE (%), BY SERVICE CATEGORY,
  • FIGURE 9 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, END USER, 2023 & 2032 (USD MILLION)
  • FIGURE 10 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY END USER, 2023 & 2032 (USD MILLION)
  • FIGURE 11 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET SHARE (%), BY END USER,
  • FIGURE 12 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY REGION, 2023 & 2032 (USD MILLION)
  • FIGURE 13 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET SHARE (%), BY REGION,
  • FIGURE 14 NORTH AMERICA MARKET ANALYSIS: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, 2018-2032
  • FIGURE 15 NORTH AMERICA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, BY COUNTRY, 2023 & 2032 (USD MILLION)
  • FIGURE 16 NORTH AMERICA: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET SHARE (%), BY COUNTRY,
  • FIGURE 17 EUROPE MARKET ANALYSIS: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, 2018-2032 (USD MILLION)
  • FIGURE 18 EUROPE: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET SHARE, BY COUNTRY, 2023 & 2032 (USD MILLION)
  • FIGURE 19 EUROPE: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET SHARE, BY COUNTRY, 2023 (%)
  • FIGURE 20 ASIA-PACIFIC MARKET ANALYSIS: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, 2019-2032 (USD MILLION)
  • FIGURE 21 ASIA-PACIFIC: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET SHARE, BY COUNTRY, 2023 & 2032 (USD MILLION)
  • FIGURE 22 ASIA-PACIFIC: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET SHARE, BY COUNTRY, 2023 (%)
  • FIGURE 23 REST OF THE WORLD MARKET ANALYSIS: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET, 2018-2032 (USD MILLION)
  • FIGURE 24 REST OF THE WORLD: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET SHARE, BY COUNTRY, 2023 & 2032 (USD MILLION)
  • FIGURE 25 REST OF THE WORLD: CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET SHARE, BY COUNTRY, 2023 (%)
  • FIGURE 26 GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET PLAYERS: COMPETITIVE ANALYSIS,
  • FIGURE 27 COMPETITOR DASHBOARD: GLOBAL CATHETERS AND ACTIVE IMPLANTABLE CDMO MARKET
  • FIGURE 28 INTEGER HOLDINGS CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 29 INTEGER HOLDINGS CORPORATION: SWOT ANALYSIS
  • FIGURE 30 CIRTEC: SWOT ANALYSIS
  • FIGURE 31 SWITCHBACK MEDICAL: SWOT ANALYSIS
  • FIGURE 32 HERAEUS GROUP: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 33 HERAEUS GROUP: SWOT ANALYSIS
  • FIGURE 34 ZEUS COMPANY LLC: SWOT ANALYSIS